GlassScriptPhysician profile
Christopher W Sciales
NPI 1316965007
$14,981.71
in general payments reported to CMS, 2019-2025
46 companies · $3,176 in 2025
The $3,176 reported for 2025 was more than what 85% of Dermatology providers received nationally (typical 2025 total: $772).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,244 · 2020: $1,374 · 2021: $1,676 · 2022: $1,818 · 2023: $2,192 · 2024: $2,502 · 2025: $3,176.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $7,524 · Education: $345.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $7,524.18 |
| Education | $344.93 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $2,192.30 | 2019-2025 | Rinvoq, Skyrizi |
| Sun Pharmaceutical Industries INC. | $1,384.03 | 2019-2025 | Odomzo, Blu-U, Winlevi |
| Leo Pharma INC. | $1,008.05 | 2019-2025 | Adbry, Anzupgo |
| Novartis Pharmaceuticals Corporation | $838.04 | 2019-2025 | |
| Lilly USA, LLC | $818.09 | 2019-2025 | Taltz, Olumiant, Ebglyss |
| Incyte Corporation | $755.87 | 2021-2025 | Opzelura |
| Mayne Pharma Commercial LLC | $699.75 | 2019-2025 | |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $684.25 | 2019-2024 | Jublia, Arazlo, Cabtreo |
| Janssen Biotech, INC. | $680.78 | 2019-2025 | Tremfya, Simponi Aria, Simponi |
| Pfizer INC. | $639.89 | 2019-2025 | |
| Amgen INC. | $618.49 | 2020-2025 | Otezla, Otezla |
| Galderma Laboratories, L.P. | $601.24 | 2019-2025 | Nemluvio, Aklief |
| Merz North America, INC. | $562.76 | 2019-2021 | |
| Regeneron Healthcare Solutions, INC. | $559.80 | 2020-2025 | Dupixent, Libtayo |
| E.R. Squibb & Sons, L.L.C. | $475.61 | 2022-2025 | Sotyktu |
Show all 46 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Christopher Sciales listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.